Will PCSK9 Inhibitors Transform the Natural History of Atherosclerosis?

Presenter: Philippe Gabriel Steg

REGISTER for free or LOG IN to view this content

Will PCSK9 Inhibitors Transform the Natural History of Atherosclerosis?

Up Next

More slides +

We Recommend